Biotechnology: Global Industry Guide
Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
Highlights
The global biotechnology market grew by 4% in 2009 to reach a value of $200.9 billion.
In 2014, the global biotechnology market is forecast to have a value of $318.4 billion, an increase of 58.5% since 2009.
Medical/Healthcare is the largest segment of the global biotechnology market, accounting for 66.2% of the market's total value.
Americas accounts for 48.4% of the global biotechnology market value.
Rapid market growth should encourage new players into the fray, but rivalry is assessed as moderate in a market where the typical player is an SME.
Why you should buy this report
The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this market from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates
Scope of the Report
- Contains an executive summary and data on value, volume and segmentation
- Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companie
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
- Includes a five-year forecast of the industry
Highlights
The global biotechnology market grew by 4% in 2009 to reach a value of $200.9 billion.
In 2014, the global biotechnology market is forecast to have a value of $318.4 billion, an increase of 58.5% since 2009.
Medical/Healthcare is the largest segment of the global biotechnology market, accounting for 66.2% of the market's total value.
Americas accounts for 48.4% of the global biotechnology market value.
Rapid market growth should encourage new players into the fray, but rivalry is assessed as moderate in a market where the typical player is an SME.
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this market from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates
Contents
EXECUTIVE SUMMARYINTRODUCTION
What is this report about?
Who is the target reader?
Market definition
GLOBAL BIOTECHNOLOGY
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
BIOTECHNOLOGY IN ASIAPACIFIC
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
BIOTECHNOLOGY IN EUROPE
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
BIOTECHNOLOGY IN BELGIUM
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN CANADA
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN CHINA
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN FRANCE
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN GERMANY
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN ITALY
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN JAPAN
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN THE NETHERLANDS
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN SPAIN
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN THE UNITED KINGDOM
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
BIOTECHNOLOGY IN THE UNITED STATES
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
Macroeconomic Indicators
COMPANY PROFILES
Leading Companies
APPENDIX
Data Research Methodology
About Datamonitor
Disclaimer
LIST OF TABLES
Table 1: Global biotechnology market value: $ billion, 2005–09
Table 2: Global biotechnology market segmentation I:% share, by value, 2009
Table 3: Global biotechnology market segmentation II: % share, by value, 2009
Table 4: Global biotechnology market value forecast: $ billion, 2009–14
Table 5: Asia-Pacific biotechnology market value: $ billion, 2005–09
Table 6: Asia-Pacific biotechnology market segmentation I:% share, by value, 2009
Table 7: Asia-Pacific biotechnology market segmentation II: % share, by value, 2009
Table 8: Asia-Pacific biotechnology market value forecast: $ billion, 2009–14
Table 9: Europe biotechnology market value: $ billion, 2005–09
Table 10: Europe biotechnology market segmentation I:% share, by value, 2009
Table 11: Europe biotechnology market segmentation II: % share, by value, 2009
Table 12: Europe biotechnology market value forecast: $ billion, 2009–14
Table 13: Belgium biotechnology market value: $ billion, 2005–09
Table 14: Belgium biotechnology market segmentation I:% share, by value, 2009
Table 15: Belgium biotechnology market segmentation II: % share, by value, 2009
Table 16: Belgium biotechnology market value forecast: $ billion, 2009–14
Table 17: Belgium size of population (million), 2005–09
Table 18: Belgium gdp (constant 2000 prices, $ billion), 2005–09
Table 19: Belgium gdp (current prices, $ billion), 2005–09
Table 20: Belgium inflation, 2005–09
Table 21: Belgium consumer price index (absolute), 2005–09
Table 22: Belgium exchange rate, 2005–09
Table 23: Canada biotechnology market value: $ billion, 2005–09
Table 24: Canada biotechnology market segmentation I:% share, by value, 2009
Table 25: Canada biotechnology market segmentation II: % share, by value, 2009
Table 26: Canada biotechnology market value forecast: $ billion, 2009–14
Table 27: Canada size of population (million), 2005–09
Table 28: Canada gdp (constant 2000 prices, $ billion), 2005–09
Table 29: Canada gdp (current prices, $ billion), 2005–09
Table 30: Canada inflation, 2005–09
Table 31: Canada consumer price index (absolute), 2005–09
Table 32: Canada exchange rate, 2005–09
Table 33: China biotechnology market value: $ billion, 2005–09
Table 34: China biotechnology market segmentation I:% share, by value, 2009
Table 35: China biotechnology market segmentation II: % share, by value, 2009
Table 36: China biotechnology market value forecast: $ billion, 2009–14
Table 37: China size of population (million), 2005–09
Table 38: China gdp (constant 2000 prices, $ billion), 2005–09
Table 39: China gdp (current prices, $ billion), 2005–09
Table 40: China inflation, 2005–09
Table 41: China consumer price index (absolute), 2005–09
Table 42: China exchange rate, 2005–09
Table 43: France biotechnology market value: $ billion, 2005–09
Table 44: France biotechnology market segmentation I:% share, by value, 2009
Table 45: France biotechnology market segmentation II: % share, by value, 2009
Table 46: France biotechnology market value forecast: $ billion, 2009–14
Table 47: France size of population (million), 2005–09
Table 48: France gdp (constant 2000 prices, $ billion), 2005–09
Table 49: France gdp (current prices, $ billion), 2005–09
Table 50: France inflation, 2005–09
Table 51: France consumer price index (absolute), 2005–09
Table 52: France exchange rate, 2005–09
Table 53: Germany biotechnology market value: $ billion, 2005–09
Table 54: Germany biotechnology market segmentation I:% share, by value, 2009
Table 55: Germany biotechnology market segmentation II: % share, by value, 2009
Table 56: Germany biotechnology market value forecast: $ billion, 2009–14
Table 57: Germany size of population (million), 2005–09
Table 58: Germany gdp (constant 2000 prices, $ billion), 2005–09
Table 59: Germany gdp (current prices, $ billion), 2005–09
Table 60: Germany inflation, 2005–09
Table 61: Germany consumer price index (absolute), 2005–09
Table 62: Germany exchange rate, 2005–09
Table 63: Italy biotechnology market value: $ billion, 2005–09
Table 64: Italy biotechnology market segmentation I:% share, by value, 2009
Table 65: Italy biotechnology market segmentation II: % share, by value, 2009
Table 66: Italy biotechnology market value forecast: $ billion, 2009–14
Table 67: Italy size of population (million), 2005–09
Table 68: Italy gdp (constant 2000 prices, $ billion), 2005–09
Table 69: Italy gdp (current prices, $ billion), 2005–09
Table 70: Italy inflation, 2005–09
Table 71: Italy consumer price index (absolute), 2005–09
Table 72: Italy exchange rate, 2005–09
Table 73: Japan biotechnology market value: $ billion, 2005–09
Table 74: Japan biotechnology market segmentation I:% share, by value, 2009
Table 75: Japan biotechnology market segmentation II: % share, by value, 2009
Table 76: Japan biotechnology market value forecast: $ billion, 2009–14
Table 77: Japan size of population (million), 2005–09
Table 78: Japan gdp (constant 2000 prices, $ billion), 2005–09
Table 79: Japan gdp (current prices, $ billion), 2005–09
Table 80: Japan inflation, 2005–09
Table 81: Japan consumer price index (absolute), 2005–09
Table 82: Japan exchange rate, 2005–09
Table 83: Netherlands biotechnology market value: $ million, 2005–09
Table 84: Netherlands biotechnology market segmentation I:% share, by value, 2009
Table 85: Netherlands biotechnology market segmentation II: % share, by value, 2009
Table 86: Netherlands biotechnology market value forecast: $ million, 2009–14
Table 87: Netherlands size of population (million), 2005–09
Table 88: Netherlands gdp (constant 2000 prices, $ billion), 2005–09
Table 89: Netherlands gdp (current prices, $ billion), 2005–09
Table 90: Netherlands inflation, 2005–09
Table 91: Netherlands consumer price index (absolute), 2005–09
Table 92: Netherlands exchange rate, 2005–09
Table 93: Spain biotechnology market value: $ billion, 2005–09
Table 94: Spain biotechnology market segmentation I:% share, by value, 2009
Table 95: Spain biotechnology market segmentation II: % share, by value, 2009
Table 96: Spain biotechnology market value forecast: $ billion, 2009–14
Table 97: Spain size of population (million), 2005–09
Table 98: Spain gdp (constant 2000 prices, $ billion), 2005–09
Table 99: Spain gdp (current prices, $ billion), 2005–09
Table 100: Spain inflation, 2005–09
Table 101: Spain consumer price index (absolute), 2005–09
Table 102: Spain exchange rate, 2005–09
Table 103: United Kingdom biotechnology market value: $ billion, 2005–09
Table 104: United Kingdom biotechnology market segmentation I:% share, by value, 2009
Table 105: United Kingdom biotechnology market segmentation II: % share, by value, 2009
Table 106: United Kingdom biotechnology market value forecast: $ billion, 2009–14
Table 107: United Kingdom size of population (million), 2005–09
Table 108: United Kingdom gdp (constant 2000 prices, $ billion), 2005–09
Table 109: United Kingdom gdp (current prices, $ billion), 2005–09
Table 110: United Kingdom inflation, 2005–09
Table 111: United Kingdom consumer price index (absolute), 2005–09
Table 112: United Kingdom exchange rate, 2005–09
Table 113: United States biotechnology market value: $ billion, 2005–09
Table 114: United States biotechnology market segmentation I:% share, by value, 2009
Table 115: United States biotechnology market segmentation II: % share, by value, 2009
Table 116: United States biotechnology market value forecast: $ billion, 2009–14
Table 117: United States size of population (million), 2005–09
Table 118: United States gdp (constant 2000 prices, $ billion), 2005–09
Table 119: United States gdp (current prices, $ billion), 2005–09
Table 120: United States inflation, 2005–09
Table 121: United States consumer price index (absolute), 2005–09
Table 122: United States exchange rate, 2005–09
Table 123: Merck KGaA: key facts
Table 124: Merck KGaA: key financials ($)
Table 125: Merck KGaA: key financials (€)
Table 126: Merck KGaA: key financial ratios
Table 127: Novartis AG: key facts
Table 128: Novartis AG: key financials ($)
Table 129: Novartis AG: key financial ratios
Table 130: Pfizer Inc.: key facts
Table 131: Pfizer Inc.: key financials ($)
Table 132: Pfizer Inc.: key financial ratios
Table 133: AstraZeneca PLC: key facts
Table 134: AstraZeneca PLC: key financials ($)
Table 135: AstraZeneca PLC: key financial ratios
LIST OF FIGURES
Figure 1: Global biotechnology market value: $ billion, 2005–09
Figure 2: Global biotechnology market segmentation I:% share, by value, 2009
Figure 3: Global biotechnology market segmentation II: % share, by value, 2009
Figure 4: Forces driving competition in the global biotechnology market, 2009
Figure 5: Drivers of buyer power in the global biotechnology market, 2009
Figure 6: Drivers of supplier power in the global biotechnology market, 2009
Figure 7: Factors influencing the likelihood of new entrants in the global biotechnology market, 2009
Figure 8: Factors influencing the threat of substitutes in the global biotechnology market, 2009
Figure 9: Drivers of degree of rivalry in the global biotechnology market, 2009
Figure 10: Global biotechnology market value forecast: $ billion, 2009–14
Figure 11: Asia-Pacific biotechnology market value: $ billion, 2005–09
Figure 12: Asia-Pacific biotechnology market segmentation I:% share, by value, 2009
Figure 13: Asia-Pacific biotechnology market segmentation II: % share, by value, 2009
Figure 14: Forces driving competition in the biotechnology market in Asia-Pacific, 2009
Figure 15: Drivers of buyer power in the biotechnology market in Asia-Pacific, 2009
Figure 16: Drivers of supplier power in the biotechnology market in Asia-Pacific, 2009
Figure 17: Factors influencing the likelihood of new entrants in the biotechnology market in Asia-Pacific, 2009
Figure 18: Factors influencing the threat of substitutes in the biotechnology market in Asia-Pacific, 2009
Figure 19: Drivers of degree of rivalry in the biotechnology market in Asia-Pacific, 2009
Figure 20: Asia-Pacific biotechnology market value forecast: $ billion, 2009–14
Figure 21: Europe biotechnology market value: $ billion, 2005–09
Figure 22: Europe biotechnology market segmentation I:% share, by value, 2009
Figure 23: Europe biotechnology market segmentation II: % share, by value, 2009
Figure 24: Forces driving competition in the biotechnology market in Europe, 2009
Figure 25: Drivers of buyer power in the biotechnology market in Europe, 2009
Figure 26: Drivers of supplier power in the biotechnology market in Europe, 2009
Figure 27: Factors influencing the likelihood of new entrants in the biotechnology market in Europe, 2009
Figure 28: Factors influencing the threat of substitutes in the biotechnology market in Europe, 2009
Figure 29: Drivers of degree of rivalry in the biotechnology market in Europe, 2009
Figure 30: Europe biotechnology market value forecast: $ billion, 2009–14
Figure 31: Belgium biotechnology market value: $ billion, 2005–09
Figure 32: Belgium biotechnology market segmentation I:% share, by value, 2009
Figure 33: Belgium biotechnology market segmentation II: % share, by value, 2009
Figure 34: Forces driving competition in the biotechnology market in Belgium, 2009
Figure 35: Drivers of buyer power in the biotechnology market in Belgium, 2009
Figure 36: Drivers of supplier power in the biotechnology market in Belgium, 2009
Figure 37: Factors influencing the likelihood of new entrants in the biotechnology market in Belgium, 2009
Figure 38: Factors influencing the threat of substitutes in the biotechnology market in Belgium, 2009
Figure 39: Drivers of degree of rivalry in the biotechnology market in Belgium, 2009
Figure 40: Belgium biotechnology market value forecast: $ billion, 2009–14
Figure 41: Canada biotechnology market value: $ billion, 2005–09
Figure 42: Canada biotechnology market segmentation I:% share, by value, 2009
Figure 43: Canada biotechnology market segmentation II: % share, by value, 2009
Figure 44: Forces driving competition in the biotechnology market in Canada, 2009
Figure 45: Drivers of buyer power in the biotechnology market in Canada, 2009
Figure 46: Drivers of supplier power in the biotechnology market in Canada, 2009
Figure 47: Factors influencing the likelihood of new entrants in the biotechnology market in Canada, 2009
Figure 48: Factors influencing the threat of substitutes in the biotechnology market in Canada, 2009
Figure 49: Drivers of degree of rivalry in the biotechnology market in Canada, 2009
Figure 50: Canada biotechnology market value forecast: $ billion, 2009–14
Figure 51: China biotechnology market value: $ billion, 2005–09
Figure 52: China biotechnology market segmentation I:% share, by value, 2009
Figure 53: China biotechnology market segmentation II: % share, by value, 2009
Figure 54: Forces driving competition in the biotechnology market in China, 2009
Figure 55: Drivers of buyer power in the biotechnology market in China, 2009
Figure 56: Drivers of supplier power in the biotechnology market in China, 2009
Figure 57: Factors influencing the likelihood of new entrants in the biotechnology market in China, 2009
Figure 58: Factors influencing the threat of substitutes in the biotechnology market in China, 2009
Figure 59: Drivers of degree of rivalry in the biotechnology market in China, 2009
Figure 60: China biotechnology market value forecast: $ billion, 2009–14
Figure 61: France biotechnology market value: $ billion, 2005–09
Figure 62: France biotechnology market segmentation I:% share, by value, 2009
Figure 63: France biotechnology market segmentation II: % share, by value, 2009
Figure 64: Forces driving competition in the biotechnology market in France, 2009
Figure 65: Drivers of buyer power in the biotechnology market in France, 2009
Figure 66: Drivers of supplier power in the biotechnology market in France, 2009
Figure 67: Factors influencing the likelihood of new entrants in the biotechnology market in France, 2009
Figure 68: Factors influencing the threat of substitutes in the biotechnology market in France, 2009
Figure 69: Drivers of degree of rivalry in the biotechnology market in France, 2009
Figure 70: France biotechnology market value forecast: $ billion, 2009–14
Figure 71: Germany biotechnology market value: $ billion, 2005–09
Figure 72: Germany biotechnology market segmentation I:% share, by value, 2009
Figure 73: Germany biotechnology market segmentation II: % share, by value, 2009
Figure 74: Forces driving competition in the biotechnology market in Germany, 2009
Figure 75: Drivers of buyer power in the biotechnology market in Germany, 2009
Figure 76: Drivers of supplier power in the biotechnology market in Germany, 2009
Figure 77: Factors influencing the likelihood of new entrants in the biotechnology market in Germany, 2009
Figure 78: Factors influencing the threat of substitutes in the biotechnology market in Germany, 2009
Figure 79: Drivers of degree of rivalry in the biotechnology market in Germany, 2009
Figure 80: Germany biotechnology market value forecast: $ billion, 2009–14
Figure 81: Italy biotechnology market value: $ billion, 2005–09
Figure 82: Italy biotechnology market segmentation I:% share, by value, 2009
Figure 83: Italy biotechnology market segmentation II: % share, by value, 2009
Figure 84: Forces driving competition in the biotechnology market in Italy, 2009
Figure 85: Drivers of buyer power in the biotechnology market in Italy, 2009
Figure 86: Drivers of supplier power in the biotechnology market in Italy, 2009
Figure 87: Factors influencing the likelihood of new entrants in the biotechnology market in Italy, 2009
Figure 88: Factors influencing the threat of substitutes in the biotechnology market in Italy, 2009
Figure 89: Drivers of degree of rivalry in the biotechnology market in Italy, 2009
Figure 90: Italy biotechnology market value forecast: $ billion, 2009–14
Figure 91: Japan biotechnology market value: $ billion, 2005–09
Figure 92: Japan biotechnology market segmentation I:% share, by value, 2009
Figure 93: Japan biotechnology market segmentation II: % share, by value, 2009
Figure 94: Forces driving competition in the biotechnology market in Japan, 2009
Figure 95: Drivers of buyer power in the biotechnology market in Japan, 2009
Figure 96: Drivers of supplier power in the biotechnology market in Japan, 2009
Figure 97: Factors influencing the likelihood of new entrants in the biotechnology market in Japan, 2009
Figure 98: Factors influencing the threat of substitutes in the biotechnology market in Japan, 2009
Figure 99: Drivers of degree of rivalry in the biotechnology market in Japan, 2009
Figure 100: Japan biotechnology market value forecast: $ billion, 2009–14
Figure 101: Netherlands biotechnology market value: $ million, 2005–09
Figure 102: Netherlands biotechnology market segmentation I:% share, by value, 2009
Figure 103: Netherlands biotechnology market segmentation II: % share, by value, 2009
Figure 104: Forces driving competition in the biotechnology market in the Netherlands, 2009
Figure 105: Drivers of buyer power in the biotechnology market in the Netherlands, 2009
Figure 106: Drivers of supplier power in the biotechnology market in the Netherlands, 2009
Figure 107: Factors influencing the likelihood of new entrants in the biotechnology market in the Netherlands, 2009
Figure 108: Factors influencing the threat of substitutes in the biotechnology market in the Netherlands, 2009
Figure 109: Drivers of degree of rivalry in the biotechnology market in the Netherlands, 2009
Figure 110: Netherlands biotechnology market value forecast: $ million, 2009–14
Figure 111: Spain biotechnology market value: $ billion, 2005–09
Figure 112: Spain biotechnology market segmentation I:% share, by value, 2009
Figure 113: Spain biotechnology market segmentation II: % share, by value, 2009
Figure 114: Forces driving competition in the biotechnology market in Spain, 2009
Figure 115: Drivers of buyer power in the biotechnology market in Spain, 2009
Figure 116: Drivers of supplier power in the biotechnology market in Spain, 2009
Figure 117: Factors influencing the likelihood of new entrants in the biotechnology market in Spain, 2009
Figure 118: Factors influencing the threat of substitutes in the biotechnology market in Spain, 2009
Figure 119: Drivers of degree of rivalry in the biotechnology market in Spain, 2009
Figure 120: Spain biotechnology market value forecast: $ billion, 2009–14
Figure 121: United Kingdom biotechnology market value: $ billion, 2005–09
Figure 122: United Kingdom biotechnology market segmentation I:% share, by value, 2009
Figure 123: United Kingdom biotechnology market segmentation II: % share, by value, 2009
Figure 124: Forces driving competition in the biotechnology market in the United Kingdom, 2009
Figure 125: Drivers of buyer power in the biotechnology market in the United Kingdom, 2009
Figure 126: Drivers of supplier power in the biotechnology market in the United Kingdom, 2009
Figure 127: Factors influencing the likelihood of new entrants in the biotechnology market in the United Kingdom, 2009
Figure 128: Factors influencing the threat of substitutes in the biotechnology market in the United Kingdom, 2009
Figure 129: Drivers of degree of rivalry in the biotechnology market in the United Kingdom, 2009
Figure 130: United Kingdom biotechnology market value forecast: $ billion, 2009–14
Figure 131: United States biotechnology market value: $ billion, 2005–09
Figure 132: United States biotechnology market segmentation I:% share, by value, 2009
Figure 133: United States biotechnology market segmentation II: % share, by value, 2009
Figure 134: Forces driving competition in the biotechnology market in the United States, 2009
Figure 135: Drivers of buyer power in the biotechnology market in the United States, 2009
Figure 136: Drivers of supplier power in the biotechnology market in the United States, 2009
Figure 137: Factors influencing the likelihood of new entrants in the biotechnology market in the United States, 2009
Figure 138: Factors influencing the threat of substitutes in the biotechnology market in the United States, 2009
Figure 139: Drivers of degree of rivalry in the biotechnology market in the United States, 2009
Figure 140: United States biotechnology market value forecast: $ billion, 2009–14
Figure 141: Merck KGaA: revenues & profitability
Figure 142: Merck KGaA: assets & liabilities
Figure 143: Novartis AG: revenues & profitability
Figure 144: Novartis AG: assets & liabilities
Figure 145: Pfizer Inc.: revenues & profitability
Figure 146: Pfizer Inc.: assets & liabilities
Figure 147: AstraZeneca PLC: revenues & profitability
Figure 148: AstraZeneca PLC: assets & liabilities
Skip to top